Logo image of IUR.DE

KAP AG (IUR.DE) Stock Fundamental Analysis

FRA:IUR - Deutsche Boerse Ag - DE0006208408 - Common Stock - Currency: EUR

10.9  0 (0%)

Fundamental Rating

2

Taking everything into account, IUR scores 2 out of 10 in our fundamental rating. IUR was compared to 15 industry peers in the Industrial Conglomerates industry. IUR may be in some trouble as it scores bad on both profitability and health. IUR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

IUR had negative earnings in the past year.
IUR had a positive operating cash flow in the past year.
In the past 5 years IUR reported 4 times negative net income.
In the past 5 years IUR always reported a positive cash flow from operatings.
IUR.DE Yearly Net Income VS EBIT VS OCF VS FCFIUR.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M

1.2 Ratios

The Return On Assets of IUR (-17.76%) is worse than 93.33% of its industry peers.
IUR's Return On Equity of -38.65% is on the low side compared to the rest of the industry. IUR is outperformed by 93.33% of its industry peers.
Industry RankSector Rank
ROA -17.76%
ROE -38.65%
ROIC N/A
ROA(3y)-6.1%
ROA(5y)-1.54%
ROE(3y)-13.28%
ROE(5y)-4.05%
ROIC(3y)N/A
ROIC(5y)N/A
IUR.DE Yearly ROA, ROE, ROICIUR.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

Looking at the Gross Margin, with a value of 59.04%, IUR is in the better half of the industry, outperforming 73.33% of the companies in the same industry.
In the last couple of years the Gross Margin of IUR has grown nicely.
IUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.1%
GM growth 5Y2.29%
IUR.DE Yearly Profit, Operating, Gross MarginsIUR.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

2

2. Health

2.1 Basic Checks

IUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IUR remains at a similar level compared to 1 year ago.
IUR has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, IUR has a worse debt to assets ratio.
IUR.DE Yearly Shares OutstandingIUR.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
IUR.DE Yearly Total Debt VS Total AssetsIUR.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

IUR has an Altman-Z score of 1.37. This is a bad value and indicates that IUR is not financially healthy and even has some risk of bankruptcy.
IUR has a worse Altman-Z score (1.37) than 80.00% of its industry peers.
IUR has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
IUR has a Debt to Equity ratio of 0.44. This is in the better half of the industry: IUR outperforms 73.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 1.37
ROIC/WACCN/A
WACC7.34%
IUR.DE Yearly LT Debt VS Equity VS FCFIUR.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

IUR has a Current Ratio of 1.38. This is a normal value and indicates that IUR is financially healthy and should not expect problems in meeting its short term obligations.
IUR has a worse Current ratio (1.38) than 66.67% of its industry peers.
IUR has a Quick Ratio of 1.38. This is a bad value and indicates that IUR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.81, IUR is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.38
Quick Ratio 0.81
IUR.DE Yearly Current Assets VS Current LiabilitesIUR.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

IUR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14575.00%.
IUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.59%.
IUR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.64% yearly.
EPS 1Y (TTM)-14575%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13000%
Revenue 1Y (TTM)-11.59%
Revenue growth 3Y-9.94%
Revenue growth 5Y-6.64%
Sales Q2Q%-70.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IUR.DE Yearly Revenue VS EstimatesIUR.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

IUR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IUR.DE Price Earnings VS Forward Price EarningsIUR.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IUR is valued cheaper than 93.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.61
IUR.DE Per share dataIUR.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

6

5. Dividend

5.1 Amount

IUR has a Yearly Dividend Yield of 10.87%, which is a nice return.
IUR's Dividend Yield is rather good when compared to the industry average which is at 3.80. IUR pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, IUR pays a better dividend.
Industry RankSector Rank
Dividend Yield 10.87%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
IUR.DE Yearly Dividends per shareIUR.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2021 2022 2023 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A
IUR.DE Yearly Income VS Free CF VS DividendIUR.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

More info and screens

KAP AG

FRA:IUR (6/10/2025, 7:00:00 PM)

10.9

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryIndustrial Conglomerates
Earnings (Last)03-12 2025-03-12
Earnings (Next)08-29 2025-08-29
Inst Owners0.24%
Inst Owner ChangeN/A
Ins Owners25.7%
Ins Owner ChangeN/A
Market Cap84.69M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.87%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF 5.06
P/B 0.72
P/tB 0.83
EV/EBITDA 2.61
EPS(TTM)-5.87
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)2.16
OCFY19.78%
SpS32.5
BVpS15.2
TBVpS13.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.76%
ROE -38.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.04%
FCFM N/A
ROA(3y)-6.1%
ROA(5y)-1.54%
ROE(3y)-13.28%
ROE(5y)-4.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.1%
GM growth 5Y2.29%
F-Score4
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA 1.08
Cap/Depr 42.95%
Cap/Sales 10.48%
Interest Coverage N/A
Cash Conversion 34.76%
Profit Quality N/A
Current Ratio 1.38
Quick Ratio 0.81
Altman-Z 1.37
F-Score4
WACC7.34%
ROIC/WACCN/A
Cap/Depr(3y)65.33%
Cap/Depr(5y)78.67%
Cap/Sales(3y)10.8%
Cap/Sales(5y)9.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14575%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13000%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.59%
Revenue growth 3Y-9.94%
Revenue growth 5Y-6.64%
Sales Q2Q%-70.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y59.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.53%
OCF growth 3Y26.34%
OCF growth 5Y-13.95%